MyAverix Finance
F · Healthcare
SIMCERE PHARMAC. GRP LTD (S2P)
Drug Manufacturers - Specialty & Generic
SIMCERE PHARMAC. GRP LTD (S2P) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $3.48B, P/E ratio is 18.86, net margin is 17.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for S2P
SIMCERE PHARMAC. GRP LTD (S2P) — FAQ
What is SIMCERE PHARMAC. GRP LTD's market cap?
SIMCERE PHARMAC. GRP LTD (S2P) has a reported market cap of $3.48B (data as of 2026-03-30).
What is S2P's P/E ratio?
The price-to-earnings (P/E) ratio for SIMCERE PHARMAC. GRP LTD (S2P) is 18.86 (data as of 2026-03-30).
Does SIMCERE PHARMAC. GRP LTD pay a dividend?
Dividend yield is not available in the current snapshot for SIMCERE PHARMAC. GRP LTD (S2P). Check the MyAverix Finance app for the latest dividend data.
What sector is SIMCERE PHARMAC. GRP LTD in?
SIMCERE PHARMAC. GRP LTD (S2P) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is S2P listed on?
S2P is listed on F.
What is SIMCERE PHARMAC. GRP LTD's net margin?
SIMCERE PHARMAC. GRP LTD (S2P) reports a net margin of 17.4% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.